Cheng Li
Directeur de la Recherche - Actions chez Oppenheimer & Co., Inc. (Broker)
Profil
Cheng Li is currently the Director of Biotech Equity Research at Oppenheimer & Co., Inc. (Broker).
Prior to this role, Dr. Li obtained an undergraduate degree from The Hong Kong Polytechnic University.
Dr. Li then pursued graduate studies at Weill Cornell Graduate School of Medical Sciences, where he earned a graduate degree in 2018 and a doctorate degree in 2017.
Postes actifs de Cheng Li
Sociétés | Poste | Début |
---|---|---|
Oppenheimer & Co., Inc. (Broker)
Oppenheimer & Co., Inc. (Broker) Investment Banks/BrokersFinance Oppenheimer & Co., Inc. (Broker) (Oppenheimer-Broker) is the global full-service brokerage division of Oppenheimer & Co., Inc., an investment boutique headquartered in New York City with additional offices nationwide. Founded in 1975, the firm is owned directly by Viner Finance Inc., an indirect subsidiary of Oppenheimer Holdings Inc. (NYSE: OPY). Oppenheimer-Broker offers a full array of brokerage services to retail, institutional, and corporate clients. | Directeur de la Recherche - Actions | 01/04/2020 |
Formation de Cheng Li
The Hong Kong Polytechnic University | Undergraduate Degree |
Weill Cornell Graduate School of Medical Sciences | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Oppenheimer & Co., Inc. (Broker)
Oppenheimer & Co., Inc. (Broker) Investment Banks/BrokersFinance Oppenheimer & Co., Inc. (Broker) (Oppenheimer-Broker) is the global full-service brokerage division of Oppenheimer & Co., Inc., an investment boutique headquartered in New York City with additional offices nationwide. Founded in 1975, the firm is owned directly by Viner Finance Inc., an indirect subsidiary of Oppenheimer Holdings Inc. (NYSE: OPY). Oppenheimer-Broker offers a full array of brokerage services to retail, institutional, and corporate clients. | Finance |